02 July 2013
Ministry of Health simplified rules of an extract of recipes on drugs
RU.Facts
Since July 1 in Russia the order of an extract of recipes on narcotic and psychotropic preparations became simpler. The relevant document as "The Russian newspaper" reports, was approved by Ministry of Health of the Russian Federation.
28 June 2013
The Voice of Russia
Actually ROSNANO was established almost 6 years ago and we actively invest in projects in companies which do high tech and we actively look at the companies out of Russia obviously, understanding that there are great technologies which are not yet in Russia would like to bring them here.
28 June 2013
Ñost of healthcare in Russia will amount to 6% of GDP by 2020 - deputy PM
The Voice of Russia
11 June 2013
The pharmaceutical market in Russia - current status, trends and changes
Tomasz Domagała, CEbiotech.com
During his speech at BioForum 2013 in Budapest, Artur Shigabutdinov, from the Russian company Nadim Cro, characterized the pharmaceutical sector in Russia. He stressed the important role of generic drugs in the development of the pharmaceutical sector in the country, listed the factors stimulating development of the sector, as well as those that slow it down and talked about the changes in Russian legislation that reflect on the performance of the sector.
10 June 2013
Government obliges corporations to buy Russian technologies
Venture News
The government intends to make a list of innovative products and services which share in state companies’ purchases should be increased. The priority will be given to Russian suppliers.
10 June 2013
How to invest in Russian technoparks
Daniil Zhelobanov, Russia Beyond the Headlines
In the 2000s, the Russian government came to regard technoparks as a perfect means of fostering innovation in the country's economy. Technoparks began to spring up all over the country, thanks to numerous government programs and initiatives. Five years ago, a World Bank study confirmed that one of Russia’s provinces, the Republic of Tatarstan, had more technoparks per capita than the country which invented them — the United Kingdom.
07 June 2013
EU, Russia Sign New Agreement On Combating Illicit Drugs
RTT News
The European Union and Russia have signed a new agreement that will strengthen cooperation between the two sides in preventing drug precursors from being trafficked for the manufacture of illegal drugs, it was announced Tuesday.
06 June 2013
HemaCore Company’s device wins international design award
Venture News
Trombodynamics Analyser produced by RUSNANO’s project company HemaCore and used for the blood coagulation system diagnosis has won the Red Dot Award in the Product Design category. German company WILDDESIGN developed the instrument design by order of HemaCore Company.
06 June 2013
Recent developments in the Russian pharmaceutical industry
Debevoise & Plimpton LLP Andrew L. Bab, Kevin A. Rinker, Dmitriy A. Tartakovskiy and Anna V. Maximenko / Lexology
During the first few months of 2013, the Russian government has proposed, and in some cases adopted, new legislation that introduces a number of significant changes to the regulation of (1) the procurement of pharmaceuticals1 by Russian state-owned clinics, the Ministry of Health and other Russian federal, regional and local governmental authorities and financed from the federal, regional or municipal budgets (“Government Procurement”) and (2) the advertisement of biologically active substances and pharmaceuticals in Russia.
06 June 2013
Russia signals for stronger bilateral relation with India in healthcare sector
Suja Nair Shirodkar, PharmBiz
Russia has sent strong signal to strengthen the bilateral ties between the two countries in the healthcare sector, by inviting the Indian pharma companies and hospitals to set up their base in Russia. This was informed by the top representatives of the Russian government, during a high level interactive meeting in Mumbai recently.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.